305 related articles for article (PubMed ID: 29941637)
1. Ceftaroline Resistance by Clone-Specific Polymorphism in Penicillin-Binding Protein 2a of Methicillin-Resistant Staphylococcus aureus.
Lee H; Yoon EJ; Kim D; Kim JW; Lee KJ; Kim HS; Kim YR; Shin JH; Shin JH; Shin KS; Kim YA; Uh Y; Jeong SH
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941637
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective.
Alm RA; McLaughlin RE; Kos VN; Sader HS; Iaconis JP; Lahiri SD
J Antimicrob Chemother; 2014 Aug; 69(8):2065-75. PubMed ID: 24777906
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
[TBL] [Abstract][Full Text] [Related]
5. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.
Mendes RE; Tsakris A; Sader HS; Jones RN; Biek D; McGhee P; Appelbaum PC; Kosowska-Shick K
J Antimicrob Chemother; 2012 Jun; 67(6):1321-4. PubMed ID: 22398650
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
[TBL] [Abstract][Full Text] [Related]
8. Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
Kelley WL; Jousselin A; Barras C; Lelong E; Renzoni A
Antimicrob Agents Chemother; 2015 Apr; 59(4):1922-30. PubMed ID: 25583724
[TBL] [Abstract][Full Text] [Related]
9. PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK.
Harrison EM; Ba X; Blane B; Ellington MJ; Loeffler A; Hill RL; Holmes MA; Peacock SJ
J Antimicrob Chemother; 2016 Jan; 71(1):268-9. PubMed ID: 26462986
[No Abstract] [Full Text] [Related]
10. PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.
Long SW; Olsen RJ; Mehta SC; Palzkill T; Cernoch PL; Perez KK; Musick WL; Rosato AE; Musser JM
Antimicrob Agents Chemother; 2014 Nov; 58(11):6668-74. PubMed ID: 25155594
[TBL] [Abstract][Full Text] [Related]
11. Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA.
Schaumburg F; Peters G; Alabi A; Becker K; Idelevich EA
J Antimicrob Chemother; 2016 Jan; 71(1):41-4. PubMed ID: 26443816
[TBL] [Abstract][Full Text] [Related]
12. Genotypic analysis of Italian MRSA strains exhibiting low-level ceftaroline and ceftobiprole resistance.
Bongiorno D; Mongelli G; Stefani S; Campanile F
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114852. PubMed ID: 31288948
[TBL] [Abstract][Full Text] [Related]
13. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
[TBL] [Abstract][Full Text] [Related]
14. mecA-positive methicillin-sensitive Staphylococcus aureus clinical isolates in Zenica-Doboj Canton, Bosnia and Herzegovina.
Kamberović F; Ibrahimagić A; Uzunović S; Budimir A; Rijnders MI; Stobberingh EE
J Chemother; 2015; 27(6):330-6. PubMed ID: 25112955
[TBL] [Abstract][Full Text] [Related]
15. High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant
Morroni G; Brenciani A; Brescini L; Fioriti S; Simoni S; Pocognoli A; Mingoia M; Giovanetti E; Barchiesi F; Giacometti A; Cirioni O
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275082
[TBL] [Abstract][Full Text] [Related]
16. Potential of Staphylococcus aureus isolates carrying different PBP2a alleles to develop resistance to ceftaroline.
Lahiri SD; Alm RA
J Antimicrob Chemother; 2016 Jan; 71(1):34-40. PubMed ID: 26483514
[TBL] [Abstract][Full Text] [Related]
17.
Gostev V; Sopova J; Kalinogorskaya O; Tsvetkova I; Lobzin Y; Klotchenko S; Sidorenko S
Microb Drug Resist; 2019 Dec; 25(10):1401-1409. PubMed ID: 31329022
[TBL] [Abstract][Full Text] [Related]
18. Comparative Genomics of Borderline Oxacillin-Resistant Staphylococcus aureus Detected during a Pseudo-outbreak of Methicillin-Resistant S. aureus in a Neonatal Intensive Care Unit.
Sawhney SS; Ransom EM; Wallace MA; Reich PJ; Dantas G; Burnham CD
mBio; 2022 Feb; 13(1):e0319621. PubMed ID: 35038924
[TBL] [Abstract][Full Text] [Related]
19. Evolution of methicillin-resistant Staphylococcus aureus: Evidence of positive selection in a penicillin-binding protein (PBP) 2a coding gene mecA.
Zhan XY; Zhu QY
Infect Genet Evol; 2018 Apr; 59():16-22. PubMed ID: 29413881
[TBL] [Abstract][Full Text] [Related]
20. Ceftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.
Singh R; Almutairi M; Alm RA; Lahiri SD; San Martin M; Chen A; Ambler JE
J Antimicrob Chemother; 2017 Oct; 72(10):2796-2803. PubMed ID: 29091195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
